Diagnostics
Creative Biolabs Expands IVD Capabilities with Integrated Protein and Nucleic Acid Detection
Creative Biolabs has enhanced its in vitro diagnostics services by integrating protein and nucleic acid detection technologies, offering researchers more comprehensive biomarker analysis for early disease detection and complex condition research.
LabConnect Appoints Industry Veteran Bill Finger to Lead Global Strategic Services
LabConnect has appointed Bill Finger as Senior Vice President of Global Strategic Services, bringing over 25 years of diagnostics and clinical research expertise to enhance the company's capabilities in complex clinical trials.
Plus Therapeutics Subsidiary CNSide Diagnostics Achieves CLIA Accreditation for CNS Cancer Testing Lab
CNSide Diagnostics has received CMS accreditation for its clinical laboratory, enabling broader patient access and insurance coverage for its cerebrospinal fluid assay platform used in central nervous system cancer detection.
Streamline Scientific Launches Enhanced PCR Reporting Service to Combat Antibiotic Misuse in UTI Treatment
Streamline Scientific's new PCR reporting service integrates clinical guidelines directly into test results to help physicians make more informed antibiotic prescribing decisions for urinary tract infections, addressing the critical issue of antimicrobial resistance.
VolitionRx Partners with Werfen to Advance Diagnostic Testing for Antiphospholipid Syndrome
VolitionRx has signed an agreement with Werfen to evaluate its Nu.Q NETs assay for improved detection and monitoring of antiphospholipid syndrome, potentially transforming diagnosis and management for millions of patients worldwide.
MyBioSource Launches Validated Anti-CALB2 Antibody for Neuroscience Research
MyBioSource has introduced a validated sheep anti-rat calretinin polyclonal antibody that enables advanced research into calcium signaling, neuroprotection, and neurodegeneration across multiple species.
Biotech Merger Creates OSPRI to Revolutionize Infectious Disease Testing with $30M Backing
The merger of Community Direct DX, Scienetix, and Advanta Genetics R&D into OSPRI creates a vertically-integrated molecular testing platform that reduces PCR testing costs by 20-50% and time by 50-70%, addressing critical accessibility barriers in healthcare diagnostics.
Dutch Startup Innovates with Rapid Field Test for Infectious Diseases
Spotlight Diagnostics' new test kit offers a portable solution for detecting infectious diseases like malaria and Chlamydia, addressing the urgent need for accessible diagnostics amid rising disease prevalence due to climate change.
Intelligent Bio Solutions Inc. to Showcase Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo
Intelligent Bio Solutions Inc. will present its pharmacokinetic study data at the ADLM 2025 Clinical Lab Expo, highlighting the reliability of fingerprint sweat as a non-invasive diagnostic tool for drug screening.
Hone Health's Diagnostic-First Approach Revolutionizes Preventative Care
Hone Health, under CEO Saad Alam, is transforming preventative care by focusing on early diagnostics and personalized health optimization to extend healthspan.
MS Tech Secures $1.2M R&D Grant for Early Disease Detection Biosensors
MS Tech Ltd. has been awarded a $1.2M R&D grant by the Israel Innovation Authority to advance its innovative biosensor technology for early disease screening and biomarkers diagnostics, marking a significant step forward in point-of-care diagnostics.
Growing Public Interest in Mitochondrial Function Testing Highlights Advances in Health and Longevity
The increasing public interest in mitochondrial health testing underscores significant advancements in addressing mitochondrial dysfunction and its implications for overall wellness and longevity.
Axim Biotechnologies Seeks FDA CLIA Waiver for Lactoferrin Diagnostic Test
Axim Biotechnologies has taken a significant step towards broadening access to its Lactoferrin diagnostic test by filing a Pre-Submission with the FDA for a CLIA Waiver, aiming to facilitate easier diagnosis and monitoring of Aqueous Deficient Dry Eye Disease.
Study Highlights Delayed Cancer Diagnosis in Younger Populations
Research from the University of Nottingham shows younger individuals with certain cancers face longer diagnosis times, underscoring the need for improved detection and treatment strategies.
Frame and Labcorp Partner to Revolutionize Fertility Care Access
Frame, a virtual fertility care platform, collaborates with Labcorp to address the critical gaps in fertility care, offering timely diagnostics and personalized support to individuals navigating their fertility journey.
Intelligent Bio Solutions Advances Non-Invasive Drug Testing Technology for U.S. Market
Intelligent Bio Solutions is progressing toward FDA clearance for a groundbreaking fingerprint-based drug screening system with 94.1% accuracy, positioning the company for potential expansion across safety-critical industries in the United States.
Breakthrough Brain Tumor Test Promises Faster Diagnosis
A new diagnostic test for brain tumors could dramatically reduce the time needed for accurate diagnosis, potentially improving patient outcomes by enabling quicker treatment decisions.
Creative Biolabs Advances Exosome Research with Enhanced Platform Capabilities
Creative Biolabs has upgraded its Extracellular Vesicle platform, offering more precise exosome isolation, characterization, and RNA sequencing techniques that could accelerate disease research and diagnostic capabilities.
Viral TikTok Video Highlights Simple Hand Motion Test for Potential Brain Tumor Detection
A social media trend reveals a 30-second hand test that could help individuals identify potential undiagnosed brain health issues, raising awareness about early symptom recognition.
Rapid Diagnostic Test Developed for Bacterial Meningitis
Researchers at Amsterdam University Medical Center have created a new diagnostic test that can quickly and accurately detect bacterial meningitis by measuring protein levels in cerebrospinal fluid, potentially improving patient outcomes through faster diagnosis.
Fifty 1 Labs Launches BioSentry Division, Appoints New CEO to Advance Biohazard Detection Technology
Fifty 1 Labs has appointed Michael Lawson as CEO and established a new BioSentry Division focused on developing advanced real-time sensor systems for detecting biological, chemical, and environmental threats across multiple sectors.
Fidget Spinner Transforms into Rapid Bacterial Detection Device
Researchers have developed a novel diagnostic tool using a fidget spinner with nanoplasmonic technology to detect bacterial species quickly and accurately. This innovative device could revolutionize point-of-care diagnostics, especially in resource-limited settings.
ProPhase Labs Sells Subsidiaries for $23.6M, Streamlines Business Focus
ProPhase Labs has completed the sale of its Pharmaloz subsidiaries to a private equity group, eliminating over $20 million in debt and positioning the company to concentrate on its core biotech and diagnostics businesses.
Breakthrough Blood Test Could Revolutionize Early Stroke Treatment
A new blood test measuring brain protein levels shows promise in quickly distinguishing between bleeding and clot-based strokes before patients reach the hospital, potentially transforming emergency stroke care and improving patient outcomes.